Clinical Research Management Briefing - April 30, 2018
The grant from the National Institutes of Health will fund the Clinical and Translational Science Award (CTSA) program for an additional five years.
Translational Research Newsroom, April 24
A controversial study, where participants are injected with small amounts of the Zika virus, has bioethicists and researchers at odds about whether the benefits of the study outweigh the risks.
The New York Times, April 20
The U.S. Food and Drug Administration (FDA) issued draft guidance to assist sponsors of rare disease drug development programs with updated recommendations.
Regulatory Focus, April 23
Research regulators are reevaluating enrollment criteria to ensure relevant populations are incorporated at all stages of clinical trials.
Applied Clinical Trials, April 24
Financial and Operations
Both patients and researchers would benefit from increased patient involvement during the planning, development and outcome stages of research.
PatientEngagementHIT, April 13
Increased efficiency and reduced costs are among some of the benefits of using artificial intelligence (AI) in clinical trials.
MedCity News, April 24
NGMC sees financial improvement, faster turnaround times and enhanced service after implementing Huron Research Office.